
Opioid Damages and Health Care Costs Recovery Act
[SBC 2018] CHAPTER 35




where


mms


is the manufacturer's market share for the type of opioid
product from the date of the earliest opioid-related wrong
committed by that manufacturer to the date of trial;



mm


is the quantity of the type of opioid product manufactured by
the manufacturer that is distributed, sold or offered for sale
within British Columbia from the date of the earliest
opioid-related wrong committed by that manufacturer to the date
of trial;



MM


is the quantity of the type of opioid product manufactured by
all manufacturers that is purchased or dispensed within British
Columbia for the purpose of providing health care benefits from
the date of the earliest opioid-related wrong committed by the
manufacturer to the date of trial.


